RN7SL113P

Across TCGA pan-cancer cohorts, RN7SL113P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RN7SL113P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL113P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL113P expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

BLCA, LUAD, and LGG are the cancer types where RN7SL113P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.459	0.249	<.001	97	view →
LUAD	OS	Median	II,III,IV	0.411	0.163	.003	40	view →
LGG	DFS	Median	All	0.668	0.804	<.001	37	view →
KIRP	DFS	Median	IV	0.037	0.526	.011	36	view →
KIRC	OS	Median	All	0.548	0.697	<.001	31	view →
BRCA	OS	Tertile	III,IV	0.865	0.743	.018	16	view →
READ	DFS	Tertile	All	0.396	0.781	.001	14	view →
MESO	DFS	Tertile	III,IV	0.777	0.163	.006	13	view →
UVM	OS	Tertile	III,IV	0.326	1.000	.021	12	view →
COAD	OS	Median	All	0.859	0.729	.016	10	view →
CHOL	DFS	Quartile	All	0.162	0.586	.006	9	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.818	.014	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RN7SL113P–BLCA (DFS)

Open the BLCA breakdown →